DUBLIN, Jan. 10, 2020 — (PRNewswire) — The "Global 3D Bioprinting Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
The global 3D bioprinting market is anticipated to grow at a significant rate during the forecast period. The major factors contributing to the growth of the market include rising incidences of lifestyle-oriented diseases and massive demand for organ & tissue transplants.
For instance, as per the Health Resources and Services Administration (HRSA), in the US, 36,528 organ transplants were performed in 2018. As of January 2018, more than 113,000 people are waiting for organ transplantation. A limited number of organ donors has also contributed towards the growth of the 3D bioprinting market. According to the US Department of Health & Human Services, in every 10 minutes, an individual is added to the national transplant waiting list. The growth in the waiting list of transplants has created a potential for the 3D bio-printed implants and organs.
The global 3D bioprinting market is segmented on the basis of technology and application. On the basis of technology, the market is segmented into extrusion-based, laser-based, inkjet-based and others. Extrusion-based technology is expected to hold a significant share in the global 3D bioprinting market. Further, on the basis of application, the market is segmented into drug testing and development, 3D cell culture, tissue and organ regeneration, and others. Drug testing and development is expected to contribute significantly to the growth of the market.
The global 3D bioprinting market geographically covers the analysis of four major regions; North America (the US and Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and RoW. North America dominated the global 3D bioprinting market in 2018. A rise in the demand for organ transplantation along with reasonably higher patient disposable income and sophisticated healthcare infrastructure are some of the key drivers for the regional growth of the market.
Moreover, the market is fragmented in nature with the presence of several players. Some of the key players operating in the market include Organovo Holdings, Inc., 3D Systems Corp., CELLINK AB, Stratasys Ltd., and CollPlant Ltd. The market players are teaming up with universities and research institutes that work on grafting as well as organ regeneration technologies. In 2015, Organovo Holding Inc. participated in Cantor Fitzgerald Inaugural Healthcare Conference with an aim to increase awareness related to their current activities in 3D bioprinting market.
The report covers:
- Comprehensive research methodology of the global 3D bioprinting market.
- A detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global 3D bioprinting market.
- Insights about market determinants which are stimulating the global 3D bioprinting market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. 3D Systems Corp.
18.104.22.168. Financial Analysis
22.214.171.124. SWOT Analysis
126.96.36.199. Recent Developments
3.3.2. Organovo Holdings, Inc.
3.3.3. CELLINK AB
3.3.4. CollPlant Ltd.
3.3.5. Stratasys Ltd.
4. Market Determinants
5. Market Segmentation
5.1. Global 3D Bioprinting Market by Technology
5.1.4. Others (Microvalve-based and Stereolithography-based)
5.2. Global 3D Bioprinting Market by Application
5.2.1. Drug Testing and Development
5.2.2. 3D Cell Culture
5.2.3. Tissue and Organ Regeneration
5.2.4. Others (Food Testing)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.2.6. Rest of Europe
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3D Bioprinting Solutions
7.2. 3D Systems Corp.
7.3. Advanced BioMatrix, Inc.
7.4. Aleph Objects, Inc.
7.6. Aspect Biosystems Ltd.
7.7. CELLINK AB
7.8. CollPlant Ltd.
7.9. Cyfuse Biomedical KK
7.10. Digilab, Inc.
7.11. EnvisionTEC, Inc.
7.12. Formlabs Inc.
7.13. GeSiM GmbH
7.14. Materialise NV
7.15. Medprin Biotech GmbH
7.16. Nano3D Biosciences, Inc.
7.17. Organovo Holdings Inc.
7.19. REGEMAT 3D S.L.
7.20. regenHU Ltd.
7.21. Regenovo Biotechnology Co. Ltd.
7.22. Stratasys, Ltd.
7.23. United Therapeutics Corp.
For more information about this report visit https://www.researchandmarkets.com/r/cjmih5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content: http://www.prnewswire.com/news-releases/3d-bioprinting-industry-study-2019-2025---leading-players-are-organovo-holdings-3d-systems-cellink-stratasys-and-collplant-300984895.html
SOURCE Research and Markets
|Company Name: Research and Markets